Management of Ventricular Tachycardia with Elevated NT-proBNP

Immediate Acute Management

The American College of Cardiology recommends immediate synchronized electrical cardioversion for hemodynamically unstable VT, starting at 100 J monophasic energy, with escalating energies if initially unsuccessful 1, 2.
For sustained polymorphic VT, the American College of Cardiology recommends unsynchronized electrical shock at 200 J initially, followed by 200-300 J, then 360 J if needed 1, 2, 3.
The American College of Cardiology suggests that hemodynamically stable sustained monomorphic VT can be treated with intravenous amiodarone or procainamide, though electrical cardioversion remains preferred 1, 2.

The American College of Cardiology recommends amiodarone as the first-line antiarrhythmic for VT refractory to electrical cardioversion: give 300 mg IV bolus followed by repeat cardioversion 1, 2.
The European Society of Cardiology recommends that beta-blockers should be initiated early, as they reduce recurrent arrhythmias and are recommended for all patients without contraindications 4.

The European Society of Cardiology mandates coronary angiography within 2 hours for life-threatening ventricular arrhythmias, as VT in the setting of elevated NT-proBNP strongly suggests acute myocardial ischemia or infarction 4.
The European Society of Cardiology recommends prompt complete coronary revascularization if ischemia is identified, as this treats the underlying cause and prevents recurrent VT/VF 4.

Echocardiography is mandatory to assess left ventricular ejection fraction, regional wall motion abnormalities, and structural heart disease, according to Praxis Medical Insights 7.

The European Society of Cardiology recommends radiofrequency catheter ablation at a specialized center for recurrent VT or electrical storm despite optimal medical therapy, followed by ICD implantation 4.
The European Society of Cardiology suggests mechanical circulatory support should be considered in hemodynamically unstable patients with recurrent VT/VF despite optimal therapy 4.

The American College of Cardiology indicates ICD implantation for patients with VF or hemodynamically significant sustained VT occurring >2 days after MI, provided the arrhythmia is not due to transient/reversible ischemia 3, 8, 9.
The American College of Cardiology recommends oral beta-blockers must be continued indefinitely in all patients without contraindications 4.

The American College of Cardiology warns never to delay electrical cardioversion in unstable VT to attempt pharmacologic conversion—this increases mortality 1, 2.
Praxis Medical Insights advises against using calcium channel blockers for wide-complex tachycardia of unknown origin, especially with myocardial dysfunction 7.
The American College of Cardiology and Praxis Medical Insights caution against treating isolated PVCs or nonsustained VT with antiarrhythmics unless causing hemodynamic compromise—this is contraindicated and potentially harmful 1, 2, 6, 5.